Barclays analyst Andrew Mok raised the firm’s price target on Humana (HUM) to $275 from $268 and keeps an Equal Weight rating on the shares following the earnings report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM:
- Humana Inc. Reports Strong Q2 2025 Earnings and Raises Guidance
- Humana’s Earnings Call: Positive Outlook Amid Challenges
- Humana Hold Rating: Balancing Strong Performance with Uncertainties and Strategic Challenges
- Early notable gainers among liquid option names on July 30th
- Unusually active option classes on open July 30th